Compared to the CRS group, meloxicam augmented the hippocampal content of Nrf2 and HO-1 by 204.3% (p < 0.01, Tukey post hoc test) and 138.8% (p < 0.05, Tukey post hoc test), respectively. The gene discussed is NFE2L2; the disease is congenital rubella syndrome.